Last summer, Germany’s medicines regulator quietly green-lit a psilocybin compassionate use program, the first such pathway in the European Union (see Germany Establishes EU’s First Psilocybin Compassionate Access Program). Two centres are permitted to offer psilocybin dosing at present: OVID Clinic Berlin, a private clinic in the nation’s capital, and the Central Institute of Mental Health (CIMH)…
